Abstract Body

Background: The immune system has a multitude of innate immune factors that work to counteract many different viruses. For HIV-1, such factors include APOBEC-3G, Tetherin (BST-2), SAMHD1, and, in the case of non-human primates, Trim5α. However, lentiviruses have evolved accessory proteins to counteract most, if not all of these factors. Such accessory proteins include HIV-1 Vif which degrades APOBEC-3G, HIV-1 Vpu and SIV Nef which reduce cell surface expression of Tetherin, and SIV Vpx which degrades SAMHD1. Interestingly, HIV-1 Vpr, an orthologue of SIV Vpx, does not degrade SAMHD1, and no cellular target for VPR has been identified as yet. Methodology: Recently, a cell line that is non-permissive to ΔVpr HIV-1 infection has been developed. By examining the proteomic content of viral cores from WT and ΔVpr viruses collected from this cell line, we deduced several potential candidates that could be the culprit to this restriction. One such candidate, the Inter-alpha-trypsin inhibitor heavy chain H4 (ITIH4) has been investigated in this study. We tested whether Vpr induces degradation of ITIH4. Western Blot analysis of ITIH4 expression was performed on cell lines/primary cells treated or not with IFNα. We also analyzed the effect of ITIH4 overexpression and downregulation on virion production (protein expression and virion release) and infectivity (indicator TZM-bl cells). Results: Vpr overexpression resulted in downregulation of ITIH4. Interestingly, ITIH4 overexpression efficiently degraded Vpr, and reduced its incorporation into the virus. Upon siRNA knockdown of ITIH4, VPR expression and incorporation was increased. When viruses were produced in the presence of ITIH4, a clear inhibition of viral replication was observed at two different points of the viral life cycle. First, there was a block at the production step of HIV-1, with viral production being reduced 3-5 fold. Second, there was a block at the early steps of infection after entry, with a 4-20 fold decrease in infectivity. Western Blot analysis of several cell lines and primary cells demonstrated a lack of this factor within T cells, but showed its presence within THP-1 cells and monocyte-derived macrophages, with upregulation in the presence of IFN-alpha. Conclusions: The presence of ITIH4 within the producer cell greatly reduces both the production and infectivity of progeny virions. Our data thus warrants further investigation into the exact mechanism by which ITIH4 inhibits HIV and how it interacts with Vpr.